Artivion to Participate in Upcoming Investor Conferences

ATLANTA, Oct. 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Stifel 2026 Healthcare Conference on Tuesday, November 10, 2026 at the Lotte New York Palace Hotel. The Company's presentation is scheduled to begin at 11:20 a.m. ET. The management team will also present at the upcoming 20^th Annual Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on Wednesday, November 11, 2026 at the Westin New York Grand Central Hotel. The Company's presentation is scheduled to begin at 8:00 a.m. ET.

A live webcast of both presentations can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcasts will be available for 90 days on the same website. 

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc., is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Contacts:

SOURCE Artivion, Inc.